Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Urinalysis × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 26 Specimen Handling 24 enzalutamide 22 Prednisone 20 Abiraterone Acetate 19 apalutamide 17 Androgen Antagonists 17 darolutamide 13 Leuprolide 12 Radiotherapy 10 Pluvicto 10 Radiosurgery 9 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 abiraterone 8 X-Rays 8 Goserelin 8 Biopsy 8 cabazitaxel 7 bicalutamide 7 Photons 7 Docetaxel 7 relugolix 6 prednylidene 6 luprolide acetate gel depot 6 gallium 68 PSMA-11 6 deltacortene 6 Triptorelin Pamoate 6 Gonadotropin-Releasing Hormone 6 Glutamate Carboxypeptidase II 6 Brachytherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03568188 2026-02-24

FOCALE

Hospices Civils de Lyon

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡